Everolimus t-Butyldimethylsilyl Ether with CAS No: 159351-68-5 is an impurity standard of Everolimus.
Everolimus is an immunosuppressive medication used in transplant medicine and oncology. As an inhibitor of the mammalian target of rapamycin (mTOR), everolimus interferes with cell signaling pathways involved in the regulation of cell growth, proliferation, and angiogenesis. In transplant medicine, everolimus is often used in combination with other immunosuppressive drugs to prevent organ rejection in kidney and liver transplant recipients. In oncology, everolimus has been approved for the treatment of various cancers, including advanced kidney cancer, breast cancer, and certain types of neuroendocrine tumors.
Buy high quality Everolimus t-Butyldimethylsilyl Ether from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of Everolimus t-Butyldimethylsilyl Ether

Everolimus t-Butyldimethylsilyl Ether

CAT. No. CP-E33007
CAS. No. 159351-68-5
Mol. F. C59H97NO14Si
Mol. Wt. 1072.5
Stock Status Custom Synthesis

Product Description


  • Category:Impurity Standards
  • Synonyms:NA
  • Chemical Name:42-O-t-Butyldimethylsilyloxyethyl Rapamycin

Request for Quotation : Everolimus t-Butyldimethylsilyl Ether

Please enter pack size
Please enter quantity
Please enter phone number
Enter 10 digit contact number
Enter only number
Please enter your full name
Please enter only alphabets
Please enter company name
Please enter your valid email
Please enter your valid email id
Please select country
Please select state
Please select city

Please select captcha
Please wait...